Pharmacological challenge test of the Tridimensional Personality Questionnaire in patients with social phobia and normal volunteers.
Tancer
M E
ME
Department of Psychiatry, University of North Carolina at Chapel Hill, School of Medicine, USA.
Ranc
J
J
Golden
R N
RN
D000316:Adrenergic alpha-Agonists; D001143:Arousal / Q000187:drug effects / Q000502:physiology; D001767:Blinking / Q000187:drug effects / Q000502:physiology; D003000:Clonidine; D015259:Dopamine Agents; D005277:Fenfluramine; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007980:Levodopa; D018377:Neurotransmitter Agents / Q000502:physiology*; D010555:Personality Inventory / Q000706:statistics & numerical data*; D010698:Phobic Disorders / Q000175:diagnosis* / Q000503:physiopathology / Q000523:psychology; D011388:Prolactin / Q000097:blood; D011594:Psychometrics; D017367:Selective Serotonin Reuptake Inhibitors
D000316:Adrenergic alpha-Agonists; D003000:Clonidine; D015259:Dopamine Agents; D005277:Fenfluramine; D019382:Human Growth Hormone; D006854:Hydrocortisone; D007980:Levodopa; D018377:Neurotransmitter Agents; D011388:Prolactin; D017367:Selective Serotonin Reuptake Inhibitors